Selling a Medical Practice in New Jersey

NJ Medical Practice Valuation Multiples in 2026

Medical practices trade at meaningfully higher multiples than most small businesses because of recurring revenue, insured payer base, and strong buyer competition from PE-backed platforms. The right deal structure — asset vs. equity, rollover equity, earnouts, employment agreements — can materially change what ends up in your pocket.

Here is where NJ practices are actually trading right now:

The spread inside each category is real. The difference between a 4x practice and an 8x practice is almost never clinical — it's documentation, clean financials, transferable payer contracts, associate coverage, and whether the owner can credibly stay on for 2–3 years post-close.

Who's Buying NJ Medical Practices

1. PE-backed platforms and MSOs

The most active category by far. Dermatology platforms, dental service organizations (DSOs), ophthalmology roll-ups, GI platforms, orthopedic MSOs — most are backed by mid-market private equity. They typically pay the highest multiples but expect owners to stay 2–5 years, take 20–40% of consideration in rollover equity, and sign non-competes.

2. Hospital systems and integrated networks

Hackensack Meridian, RWJBarnabas, Atlantic Health, Valley, and their downstream networks continue to acquire primary care and strategically important specialty practices. Multiples are usually lower than PE, but deal structure is cleaner and the ongoing employment role is often attractive to physicians who want to stop running a business.

3. Larger regional group practices

Mid-sized multi-specialty or single-specialty groups that are accumulating locations and provider coverage. They often pay competitive multiples for the right tuck-in and can be more flexible on structure than PE platforms.

4. Individual physicians and partnerships

For smaller, solo practices — particularly in primary care, pediatrics, OB/GYN, and some cash-based specialties — the buyer is frequently an individual physician or a 2–3 doctor partnership looking to own their own practice. These deals are more sensitive to payer mix and often use SBA financing.

What Moves Your Multiple Up

Adjusted EBITDA over $500K

The institutional buyer universe effectively opens once normalized EBITDA crosses roughly $500K–$750K. Below that, you are selling primarily to individual physicians at lower multiples. Above $1.5M, platforms compete aggressively.

Multiple providers, not just the owner

A practice where 60% of revenue is produced by the selling physician is fundamentally less valuable than one with associates, nurse practitioners, or PAs producing most of the revenue. Buyers pay for a business they can run after you; they don't pay to buy your personal practice.

Clean payer contracts and in-network status

In-network contracts with the major NJ payers (Horizon BCBSNJ, Aetna, UnitedHealthcare, Cigna, AmeriHealth, Medicare, Medicaid) that can be transferred or re-credentialed efficiently are central to value. A payer mix that's heavily out-of-network carries more risk and usually a lower multiple.

Ancillary revenue

In-office lab, imaging, pathology, aesthetic/cosmetic services, retail products, DME — anything that creates margin above pure professional fees expands both EBITDA and the multiple applied to it.

Clean, CPA-reviewed financials

At this level, tax-return-only financials don't cut it. Buyers (especially institutional) expect accrual-basis P&Ls, provider-level production reports, payer mix analyses, and a quality-of-earnings-ready chart of accounts. The single best ROI on a 12-month runway is cleaning up the books.

NJ-Specific Considerations

• Corporate Practice of Medicine (CPOM): NJ restricts who may own a medical practice. PE-backed deals are almost always structured as MSO / management services arrangements where the clinical entity remains physician-owned. Understanding this before negotiating is critical.
• DEA registration transfer: Each prescriber's DEA registration is personal and non-transferable. Buyer-side continuity planning is required.
• NJ State Board of Medical Examiners / Dental Examiners: Licensure transitions, ownership notifications, and change-of-control filings vary by specialty and require careful sequencing.
• Horizon BCBSNJ re-credentialing: Payer re-credentialing in NJ can take 90–180 days. Deal closings are often staged around credentialing milestones to avoid revenue disruption.
• Medicare / Medicaid CHOW: Change of ownership filings with CMS and NJ FamilyCare take time and must be planned, not reacted to.
• Real estate: Many NJ physicians own the building through a separate LLC. Buyers increasingly want to sign a 10–15 year lease as part of the deal — done right, this becomes a secondary revenue stream for the seller.
• Non-compete enforceability: NJ enforces reasonable physician non-competes, typically 1–2 years and 5–15 mile radius depending on specialty. These are negotiated, not boilerplate.

How to Prepare to Sell

Start 12–24 months before the transaction. Your highest-leverage moves:

• Commission accrual-basis financials and a quality-of-earnings-ready chart of accounts.
• Hire or develop associate providers to reduce owner-dependency of revenue.
• Clean up payer contracts; identify any that are underpriced or underperforming and renegotiate where possible.
• Document clinical protocols, staff roles, and operational playbooks.
• Resolve any open compliance issues (OIG, HIPAA, billing audits) before diligence begins.
• Think honestly about your post-close role: full exit, 2–3 year earnout, or long-term employed role. This drives buyer selection.

Common Questions